Copy Link Print Information

Alnuctamab

(Synonyms: EM901; CC-93269)
Kundenbewertung

Based on 1 Customer Validation

Alnuctamab (EM901) is a bispecific T-cell engager targeting BCMA and CD3, belonging to an asymmetric two-armed humanized IgG1 antibody. Alnuctamab can simultaneously bind to BCMA expressed on the surface of myeloma cells and CD3 molecules on the surface of T cells, recruiting T cells to kill tumors. Alnuctamab is used for the research of multiple myeloma. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Reinheit: 99.89%
  • CAS. Nr.: 2296827-07-9
  • Molecular Weight:192.13 kDa
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Alnuctamab
  • Experimental Validation Results for Alnuctamab
  • Experimental Validation Results for Alnuctamab
  • Experimental Validation Results for Alnuctamab
  • Alnuctamab Chemical Structure
    Alnuctamab Chemical Structure
CAS. Nr.: 2296827-07-9
Größe
Preis
Verfügbarkeit
Menge
Amount: USD 0.00
Please select quantity
or
or

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Alnuctamab Product Recommendations:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Finden Sie Ihren Händler vor Ort Your local distributor: Hycultec GmbHHycultec
  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Einloggen
Registrieren
Sign in to MedChemExpress
Neuen Account Registrieren

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    IgG1-kappa/lambda with domain crossover, trivalent

  • 1/16

    Immobilized CD3 epsilon/CD3e Protein can bind Alnuctamab. The EC50 for this effect is 0.728 ng/mL.

  • 1/16

    Immobilized BCMA/TNFRSF17 Protein, Human can bind Alnuctamab. The EC50 for this effect is 0.051 ng/mL.

  • 1/16

    Flow Cytometry analysis of K562 cells labelling BCMA (red) with Alnuctamab (HY-P99430). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 11,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Alnuctamab Chemical Structure
    1/16
  • Alnuctamab
  • Immobilized CD3 epsilon/CD3e Protein can bind Alnuctamab. The EC50 for this effect is 0.728 ng/mL.
  • Immobilized BCMA/TNFRSF17 Protein, Human can bind Alnuctamab. The EC50 for this effect is 0.051 ng/mL.
  • Flow Cytometry analysis of K562 cells labelling BCMA (red) with Alnuctamab (HY-P99430). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 11,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • IgG1-kappa/lambda with domain crossover, trivalent